Page last updated: 2024-09-03

2-(n,n-dipropyl)amino-5,6-dihydroxytetralin and n-n-propylnorapomorphine

2-(n,n-dipropyl)amino-5,6-dihydroxytetralin has been researched along with n-n-propylnorapomorphine in 1 studies

Compound Research Comparison

Studies
(2-(n,n-dipropyl)amino-5,6-dihydroxytetralin)
Trials
(2-(n,n-dipropyl)amino-5,6-dihydroxytetralin)
Recent Studies (post-2010)
(2-(n,n-dipropyl)amino-5,6-dihydroxytetralin)
Studies
(n-n-propylnorapomorphine)
Trials
(n-n-propylnorapomorphine)
Recent Studies (post-2010) (n-n-propylnorapomorphine)
3700274412

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Costall, B; Lim, SK; Naylor, RJ1

Other Studies

1 other study(ies) available for 2-(n,n-dipropyl)amino-5,6-dihydroxytetralin and n-n-propylnorapomorphine

ArticleYear
Characterisation of the mechanisms by which purported dopamine agonists reduce spontaneous locomotor activity of mice.
    European journal of pharmacology, 1981, Jul-17, Volume: 73, Issue:2-3

    Topics: Animals; Antipsychotic Agents; Apomorphine; Bromocriptine; Catecholamines; Dopamine; Dose-Response Relationship, Drug; Imidazolines; Male; Mice; Motor Activity; Prazosin; Receptors, Dopamine; Spiperone; Tetrahydronaphthalenes; Yohimbine

1981